Non-Interventional Management of Advanced Pancreatic Neuroendocrine Neoplasms in Patients with von Hippel-Lindau Disease

por Halperin, Reut, Tirosh, Amit
Publicado 2023

THU508 Does Mid-treatment Response To 177Lu-DOTATATE Predict Treatment Outcome In Patients With Neuroendocrine Neoplasms?

por Halperin, Reut, Tirosh, Amit
Publicado 2023

RF27 | LBSUN362 Germline CDKN1B Variants Type And Site Are Associated With Specific Phenotype In Multiple Endocrine Neoplasia 4

por Halperin, Reut, Tirosh, Amit
Publicado 2022

Unique Characteristics of Patients with Von Hippel–Lindau Disease Defined by Various Diagnostic Criteria

por Halperin, Reut, Arnon, Liat, Eden-Friedman, Yehudit, Tirosh, Amit
Publicado 2023

The rat rotenone model reproduces the abnormal pattern of central catecholamine metabolism found in Parkinson's disease

por Landau, Regev, Halperin, Reut, Sullivan, Patti, Zibly, Zion, Leibowitz, Avshalom, Goldstein, David S., Sharabi, Yehonatan
Publicado 2022

Dihydroxyphenylacetaldehyde Lowering Treatment Improves Locomotor and Neurochemical Abnormalities in the Rat Rotenone Model: Relevance to the Catecholaldehyde Hypothesis for the Pa...

por Khashab, Rawan, Gutman-Sharabi, Naama, Shabtai, Zehava, Landau, Regev, Halperin, Reut, Fay-Karmon, Tsviya, Leibowitz, Avshalom, Sharabi, Yehonatan
Publicado 2023